サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1636000

骨・ミネラル診断検査市場レポート：製品別、検査タイプ別、用途別、地域別、2025-2033年

Bone and Mineral Diagnostic Testing Market Report by Product, Test Type (Enzyme-Linked Immunosorbent Assay, Clinical Laboratory Improvement Amendments, and Others), Application, and Region 2025-2033

出版日
発行
IMARC
ページ情報
英文 139 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.90円
骨・ミネラル診断検査市場レポート：製品別、検査タイプ別、用途別、地域別、2025-2033年
出版日: 2025年01月10日
発行: IMARC
ページ情報: 英文 139 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

骨・ミネラル診断検査市場の世界市場規模は2024年に11億米ドルに達しました。今後、IMARC Groupは、市場は2033年までに15億米ドルに達し、2025年から2033年にかけて3.48%の成長率（CAGR）を示すと予測しています。骨関連疾患の発生件数の大幅な増加、疾患の早期診断と予防に対する需要の高まり、測定の自動化における継続的な技術進歩は、市場を牽引する主な要因のいくつかです。

骨・ミネラル診断検査は、ELISA、CLIA、RIAなどの技術を用いて実施される骨・ミネラル障害を検出し、診断と治療反応を評価します。骨・ミネラル代謝障害とは、カルシウム、リン、ビタミンDなどのミネラル欠乏により骨が弱くなる様々な状態を表す一般的な用語です。ほとんどの場合、これらの検査は非侵襲的で痛みを伴わず、投薬や投与も最小限で済み、複数の骨・ミネラル診断検査を組み合わせて実施することが多いです。X線、コンピュータ断層撮影（CT）スキャン、磁気共鳴画像法（MRI）などを用いることで、骨折、すり減り、骨の異常な位置などを特定したり、除外したりすることができます。さらに、骨密度検査（骨密度測定法または骨密度測定法としても知られている）や骨スキャン（骨シンチグラフィー）は、骨中のミネラル、骨代謝の詳細を検出し、さまざまな骨構造を描写します。このほか、骨生検や骨髄生検も骨診断検査の重要な一形態であり、細い針を用いて骨組織を切除し、疾患に関連する変化を検出します。

骨・ミネラル診断検査市場傾向：

世界レベルでの骨関連疾患の発生件数の大幅な増加が市場を牽引する重要な要因です。これに伴い、疾病の早期診断と予防に対する需要の高まりも、大衆の間で各種検査の利用を高める結果となっています。さらに、診断検査の自動化における絶え間ない技術進歩が、より短い納期と精度の高い出力を実現し、市場に有利な成長機会をもたらしています。しかし、いくつかの骨診断検査にかかるコストの増大、限られた償還、限られた検出能力は、市場の成長を抑制する重要な要因として作用しています。それとは反対に、幅広いPOC（ポイントオブケア）診断検査の拡大や予防ヘルスケアに対する人々の意識の高まりは、市場に明るい見通しをもたらしています。さらに、政府や非営利団体が、大衆の間で様々な診断検査手順に関する認識を促進するために行っている好意的な取り組みが市場を牽引しています。これとは別に、これらの病気を発症しやすい高齢者人口の増加が、骨障害の発生件数の増加につながっています。その他の市場開拓要因としては、急速な都市化、医療費の増加、メーカーによる新製品の発売、広範な研究開発活動などが挙げられます。

本レポートで扱う主な質問

  • 世界の骨・ミネラル診断検査市場はこれまでどのように推移し、今後どのように推移していくのか？
  • 骨・ミネラル診断検査市場の世界市場における促進要因、抑制要因、機会は何か？
  • 主要な地域市場とは？
  • 最も魅力的な骨・ミネラル診断検査市場はどの国か？
  • 製品別の市場内訳は？
  • 検査タイプ別の市場内訳は？
  • 用途別の市場内訳は？
  • 世界の骨・ミネラル診断検査市場の競合構造は？
  • 骨・ミネラル診断検査市場の世界市場における主要プレイヤー/企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の骨・ミネラル診断検査市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品別

  • アッセイ/消耗品
    • 市場動向
    • 市場予測
  • 機器
    • 市場動向
    • 市場予測

第7章 市場内訳：検査タイプ別

  • ELISA
    • 市場動向
    • 市場予測
  • CLIA
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳：用途別

  • ビタミンD検査
    • 市場動向
    • 市場予測
  • 骨代謝
    • 市場動向
    • 市場予測

第9章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ

第10章 促進要因・抑制要因・機会

  • 概要
  • 促進要因
  • 抑制要因
  • 機会

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbott Laboratories
    • bioMerieux SA
    • DiaSorin S.p.A.
    • Epitope Diagnostics Inc.
    • F. Hoffmann-La Roche AG
    • QuidelOrtho Corporation
    • Siemens Healthineers AG（Siemens AG）
図表

List of Figures

  • Figure 1: Global: Bone and Mineral Diagnostic Testing Market: Major Drivers and Challenges
  • Figure 2: Global: Bone and Mineral Diagnostic Testing Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Bone and Mineral Diagnostic Testing Market: Breakup by Product (in %), 2024
  • Figure 5: Global: Bone and Mineral Diagnostic Testing Market: Breakup by Test Type (in %), 2024
  • Figure 6: Global: Bone and Mineral Diagnostic Testing Market: Breakup by Application (in %), 2024
  • Figure 7: Global: Bone and Mineral Diagnostic Testing Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Bone and Mineral Diagnostic Testing (Assays/Consumables) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Bone and Mineral Diagnostic Testing (Assays/Consumables) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Bone and Mineral Diagnostic Testing (Instruments) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Bone and Mineral Diagnostic Testing (Instruments) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Bone and Mineral Diagnostic Testing (Enzyme-Linked Immunosorbent Assay (ELISA)) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Bone and Mineral Diagnostic Testing (Enzyme-Linked Immunosorbent Assay (ELISA)) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Bone and Mineral Diagnostic Testing (Clinical Laboratory Improvement Amendments (CLIA)) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Bone and Mineral Diagnostic Testing (Clinical Laboratory Improvement Amendments (CLIA)) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Bone and Mineral Diagnostic Testing (Other Test Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Bone and Mineral Diagnostic Testing (Other Test Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Bone and Mineral Diagnostic Testing (Vitamin D Testing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Bone and Mineral Diagnostic Testing (Vitamin D Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Bone and Mineral Diagnostic Testing (Bone Metabolism) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Bone and Mineral Diagnostic Testing (Bone Metabolism) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: North America: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: North America: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: United States: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: United States: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Canada: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Canada: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Asia-Pacific: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Asia-Pacific: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: China: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: China: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Japan: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Japan: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: India: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: India: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: South Korea: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: South Korea: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Australia: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Australia: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Indonesia: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Indonesia: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Others: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Others: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Europe: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Europe: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Germany: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Germany: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: France: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: France: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: United Kingdom: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: United Kingdom: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Italy: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Italy: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Spain: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Spain: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Russia: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Russia: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Others: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Others: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Latin America: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Latin America: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Brazil: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Brazil: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Mexico: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Mexico: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Others: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Others: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Middle East and Africa: Bone and Mineral Diagnostic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Middle East and Africa: Bone and Mineral Diagnostic Testing Market: Breakup by Country (in %), 2024
  • Figure 70: Middle East and Africa: Bone and Mineral Diagnostic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Global: Bone and Mineral Diagnostic Testing Industry: Drivers, Restraints, and Opportunities
  • Figure 72: Global: Bone and Mineral Diagnostic Testing Industry: Value Chain Analysis
  • Figure 73: Global: Bone and Mineral Diagnostic Testing Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Bone and Mineral Diagnostic Testing Market: Key Industry Highlights, 2024 & 2033
  • Table 2: Global: Bone and Mineral Diagnostic Testing Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Bone and Mineral Diagnostic Testing Market Forecast: Breakup by Test Type (in Million USD), 2025-2033
  • Table 4: Global: Bone and Mineral Diagnostic Testing Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 5: Global: Bone and Mineral Diagnostic Testing Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Bone and Mineral Diagnostic Testing Market: Competitive Structure
  • Table 7: Global: Bone and Mineral Diagnostic Testing Market: Key Players
目次
Product Code: SR112024A7106

The global bone and mineral diagnostic testing market size reached USD 1.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 1.5 Billion by 2033, exhibiting a growth rate (CAGR) of 3.48% during 2025-2033. A considerable increase in the incidences of bone-related diseases, the escalating demand for early disease diagnosis and prevention, and continual technological advancements in the automation of assay represent some of the key factors driving the market.

Bone and mineral diagnostic tests detect bone and mineral disorders that are performed using technologies, such as ELISA, CLIA, and RIA, to diagnose and assess treatment response. A bone and mineral metabolism disorder is a general term used to describe a range of conditions that can weaken bones due to mineral deficiencies like calcium, phosphorus, and vitamin D. In most cases, these tests are non-invasive, painless, and require minimal medication or administration, and several bone and mineral diagnostic tests are often performed using a combination method. The use of X-rays, computed tomography (CT) scans, or magnetic resonance imaging (MRI) can help identify or rule out fractures, wear and tear, and abnormal bone positions. Additionally, bone density tests (also known as bone densitometry or osteodensitometry) and bone scans (bone scintigraphy) detect the minerals in the bones, details on bone metabolism, and depict the different bone structures. Besides this, bone biopsies and bone marrow biopsies are also important forms of bone diagnostic testing, in which a thin needle is used to remove bone tissue to detect disease-related changes.

Bone and Mineral Diagnostic Testing Market Trends:

A considerable increase in the incidences of bone-related diseases on the global level is a significant factor driving the market. This can be attributed to the rising prevalence of sedentary lifestyle leading to deficiency of vitamin D. In line with this, the escalating demand for early disease diagnosis and prevention is also resulting in a higher uptake of various tests among the masses. Moreover, continual technological advancements in the automation of assay for enhanced diagnostic testing with lower turnaround times and increased accuracy in output are creating lucrative growth opportunities in the market. However, the augmenting costs of several bone diagnostic tests, limited reimbursements, along with limited detection capability are acting as significant factors that are restraining the market growth. On the contrary, the expansion of a wide range of point-of-care (POC) diagnostic tests and a considerable rise in public awareness toward preventive healthcare is creating a positive outlook for the market. The market is further driven by favorable initiatives undertaken by the government and non-profit organizations for promoting awareness about various diagnostic test procedures among the masses. Apart from this, the growing geriatric population that is more susceptible to developing these ailments is leading to the increasing incidences of bone disorders. Some of the other factors contributing to the market include rapid urbanization, rising medical expenditure, new product launches by the manufacturers, and extensive research and development (R&D) activities.

Key Market Segmentation:

Product Insights

Assays/Consumables

Instruments

Test Type Insights

Enzyme-Linked Immunosorbent Assay (ELISA)

Clinical Laboratory Improvement Amendments (CLIA)

Others

Application Insights

Vitamin D Testing

Bone Metabolism

Regional Insights

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa. According to the report, North America was the largest market for bone and mineral diagnostic testing. Some of the factors driving the North America bone and mineral diagnostic testing market include the expanding geriatric population, rising healthcare expenditure, extensive research and development (R&D) activities conducted by key players, etc.

Competitive Landscape

The report has also provided a comprehensive analysis of the competitive landscape in the global bone and mineral diagnostic testing market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Abbott Laboratories, bioMerieux SA, DiaSorin S.p.A., Epitope Diagnostics Inc., F. Hoffmann-La Roche AG, QuidelOrtho Corporation, Siemens Healthineers AG (Siemens AG), etc.

Key Questions Answered in This Report:

  • How has the global bone and mineral diagnostic testing market performed so far and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global bone and mineral diagnostic testing market?
  • What are the key regional markets?
  • Which countries represent the most attractive bone and mineral diagnostic testing markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the test type?
  • What is the breakup of the market based on the application?
  • What is the competitive structure of the global bone and mineral diagnostic testing market?
  • Who are the key players/companies in the global bone and mineral diagnostic testing market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Bone and Mineral Diagnostic Testing Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Assays/Consumables
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Instruments
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Test Type

  • 7.1 Enzyme-Linked Immunosorbent Assay (ELISA)
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Clinical Laboratory Improvement Amendments (CLIA)
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Vitamin D Testing
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Bone Metabolism
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

  • 10.1 Overview
  • 10.2 Drivers
  • 10.3 Restraints
  • 10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 bioMerieux SA
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 DiaSorin S.p.A.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Epitope Diagnostics Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 F. Hoffmann-La Roche AG
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
    • 14.3.6 QuidelOrtho Corporation
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Siemens Healthineers AG (Siemens AG)
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.